Stocks edge higher as health care gains on deal news
Source: AP-Excite
By STEVE ROTHWELL
NEW YORK (AP) Deal news gave the stock market a lift Wednesday.
Health care stocks rose after generic drugmaker Mylan bid $29 billion for rival Perrigo. That offset a slump in energy stocks prompted by a big drop in oil prices.
In Europe, oil company Royal Dutch Shell agreed to buy BG Group for $69.7 billion in cash and stock.
Corporations worldwide are seeking to increase growth through acquisitions and have announced almost $1 trillion of deals so far this year, according to data provider Dealogic. That's giving a boost to stock markets as the acquiring companies typically offer a premium for their targets.
FULL story at link.
FILE - This Oct. 2, 2014 file photo shows the facade of the New York Stock Exchange, in New York. U.S. stocks opened higher Wednesday, April 8, 2015, as investors waited for the release of minutes from the Federal Reserve's latest meeting. Investors were also waiting for companies to start reporting their first-quarter earnings. Alcoa, a metals company, will be one of the first major companies to report earnings after the close of the market. (AP Photo/Richard Drew, File)
Read more: http://apnews.excite.com/article/20150408/financial_markets-4fb43b9548.html
Midnight Writer
(21,753 posts)IronLionZion
(45,433 posts)I have this small chunk of money I've been moving around for years trying to get some return on and I've managed to kill off every market I put it in (see, gold). About a year ago I noticed that health care was doing quite well in anticipation of Obamacare wrecking the market so I stuck my little chunk in a health care mutual fund and in general it's been doing quite nicely, thank you.
I await the next industry that Obama decides to nationalize in anticipation of further investment opportunity.
wordpix
(18,652 posts)not a "leave it to the market" move to negotiate only with US Big Pharma and leave Canadian, Mexican and European drug makers out of the loop in the "competition" for drug buys.
This is going to kill O-care, Medicaid and Medicare if we don't fix it. My $23K per round chemo "allowed charge" (most of cost for drugs) vs. $3600 actual cost (according to NIH) is a case in point.
IronLionZion
(45,433 posts)Hospital systems and urgent care centers are doing very well and have been hiring new medical staff at all levels. There is a shortage of doctors and nurses at the entry levels nationwide. Medical device developers and health care IT firms have been doing well too.
More patients have access to care and a way to pay for it. The list of beneficiaries of this is longer than people think.
wordpix
(18,652 posts)My provider is Yale New Haven Hosp. The "provider charge" on my chemo bills were $40K average for each round of chemo, which according to NIH actually costs $3600. But I was told not to consider the provider charge and to look at the "allowed" charge. The allowed averaged $23K. Again, this is nowhere near $3600. And BTW, my chemo was "conventional" since the drugs used have been around for decades and they are not new, life-saving or cutting edge. Same with the nursing care/admin. and lab work. Basically, unless you're doing some new cutting edge chemo, it's an IV drip. At $44K each, the provider charge for my 12 rounds = well over $1/2 million. Again, for an IV drip. Isn't that a tad bit inflated?
IronLionZion
(45,433 posts)Should we have ceilings on prices?